Intellectual Property

Threading the biosimilar needle

Thursday, February 11, 2016 @ 7:00 PM | By Nikolas Purcell and Geoffrey Mowatt

Biosimilars, otherwise known as subsequent entry biologics or “SEBs” in Canada, are a rapidly emerging trend in health care.

Biosimilars present novel and intriguing legal issues that are quickly rising to...

To view the full article, Click Here to Subscribe
or sign up for a 14-day FREE Trial

Already a subscriber? Click here to sign in

Featured

No turning back from pandemic’s changes to justice system: CBA report

Latest

Other Areas of Practice Story image

Lawyer/mom working from home in Quebec: What’s best next step?

Civil Litigation Story image

Lawsuit alleges loss of property value due to landslides near massive B.C. Hydro development

Immigration Story image

The different immigration experiences of women and men

Criminal Time to decriminalize all drugs | Adriana Ortiz

Family Cox & Palmer adds family law partner in Halifax